Polypharmacologic Drug Screening

Polypharmacologic drug screening is the screening of pharmaceutical agents that act on multiple targets or disease pathways. Discover the latest research on polypharmacologic drug screening here,

May 27, 2020

An up-to-date overview of computational polypharmacology in modern drug discovery

Expert Opinion on Drug Discovery
Rajan ChaudhariShuxing Zhang
March 19, 2020
ReviewOpen Access

Multitargeting Compounds: A Promising Strategy to Overcome Multi-Drug Resistant Tuberculosis

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Giovanni StelitanoLaurent Roberto Chiarelli
March 18, 2020

Kendomycin Cytotoxicity against Bacterial, Fungal, and Mammalian Cells Is Due to Cation Chelation

Journal of Natural Products
Dale TranterDominic Hoepfner
March 10, 2020
Open Access

How polypharmacologic is each chemogenomics library?

Future Drug Discovery
Eric NiTimothy Cardozo
May 28, 2020
Open Access

Structure-based drug repositioning explains ibrutinib as VEGFR2 inhibitor

PloS One
Melissa F AdasmeMichael Schroeder
March 7, 2020
Open Access

Integrating computational lead optimization diagnostics with analog design and candidate selection

Future Science OA
Dimitar Yonchev, Jürgen Bajorath
February 22, 2020

A Natural Product Puts Malaria on a Low-Fat Diet

Cell Chemical Biology
Daniel LucyEdward W Tate
April 17, 2020

Bioisosteric discovery of NPA101.3, a second generation RET/VEGFR2 inhibitor optimized for single-agent polypharmacology

Journal of Medicinal Chemistry
Marialuisa MocciaFrancesca Carlomagno
May 10, 2020
Open Access

Multi-Targeting Bioactive Compounds Extracted from Essential Oils as Kinase Inhibitors

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Annalisa MarucaStefano Alcaro
April 30, 2020

Design and Synthesis of Dihydroxamic Acids as HDAC6/8/10 Inhibitors

Aubry Kern MillerNikolas Gunkel
May 31, 2020

X-ray Structure-Based Chemoinformatic Analysis Identifies Promiscuous Ligands Binding to Proteins from Different Classes with Varying Shapes

International Journal of Molecular Sciences
Christian Feldmann, Jürgen Bajorath
May 2, 2020
ReviewOpen Access

QSAR without borders

Chemical Society Reviews
Eugene N MuratovAlexander Tropsha
May 22, 2020

Drug rechanneling: a novel paradigm for cancer treatment

Seminars in Cancer Biology
Itishree KaushikSanjay K Srivastava
May 26, 2020

A Perspective on Multi-target Drugs for Alzheimer's Disease

Trends in Pharmacological Sciences
Ondrej BenekOndrej Soukup
January 23, 2020

The impact of chemoinformatics on drug discovery in the pharmaceutical industry

Expert Opinion on Drug Discovery
Karina Martinez-MayorgaGerald Maggiora
May 2, 2020
Open Access

Suramin exposure alters cellular metabolism and mitochondrial energy production in African trypanosomes

The Journal of Biological Chemistry
Martin ZoltnerMark C Field
February 8, 2020
Open Access

Discovery of Novel Inhibitors Targeting Multi-UDP-hexose Pyrophosphorylases as Anticancer Agents

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Yueqin YangKent Lai

Sign up to follow this feed and discover related papers.

Related Feeds


Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.


Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.


Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.


An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

© 2020 Meta ULC. All rights reserved